We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$190M
AUM Growth
+$5.59M
Cap. Flow
-$3.54M
Cap. Flow %
-1.87%
Top 10 Hldgs %
75.54%
Holding
58
New
3
Increased
14
Reduced
18
Closed
1

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$413K
2
LHX icon
L3Harris
LHX
+$271K
3
ENB icon
Enbridge
ENB
+$230K
4
TSLA icon
Tesla
TSLA
+$210K
5
WU icon
Western Union
WU
+$199K

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$1.83M
2
IDXX icon
Idexx Laboratories
IDXX
+$1.04M
3
ADBE icon
Adobe
ADBE
+$747K
4
CELG
Celgene Corp
CELG
+$702K
5
MSFT icon
Microsoft
MSFT
+$243K

Sector Composition

Rank Sector Weight
1 Healthcare 38.76%
2 Technology 35.67%
3 Communication Services 9.51%
4 Consumer Discretionary 4.31%
5 Financials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAOI icon
26
Applied Optoelectronics
AAOI
$7.57B
$888K 0.47%
19,775
– –
INTC icon
27
Intel
INTC
$455B
$840K 0.44%
16,890
+100
+0.6% +$5.31K
PEG icon
28
Public Service Enterprise Group
PEG
$38.2B
$819K 0.43%
15,122
– –
SLB icon
29
SLB Ltd
SLB
$73.6B
$764K 0.4%
11,400
– –
VZ icon
30
Verizon
VZ
$195B
$760K 0.4%
15,100
-100
-0.7% -$4.84K
PEP icon
31
PepsiCo
PEP
$190B
$612K 0.32%
5,625
– –
EOG icon
32
EOG Resources
EOG
$79.2B
$604K 0.32%
4,851
– –
BSX icon
33
Boston Scientific
BSX
$69.5B
$582K 0.31%
17,789
– –
GE icon
34
GE Aerospace
GE
$374B
$582K 0.31%
8,929
-1,577
-15% -$105K
BA icon
35
Boeing
BA
$171B
$580K 0.31%
1,728
+150
+10% +$51.6K
DELL icon
36
Dell
DELL
$262B
$568K 0.3%
23,938
– –
MCHP icon
37
Microchip Technology
MCHP
$40.3B
$556K 0.29%
12,230
+80
+0.7% +$3.71K
XOM icon
38
ExxonMobil
XOM
$644B
$483K 0.25%
5,836
– –
CTSH icon
39
Cognizant
CTSH
$24.9B
$482K 0.25%
6,100
– –
CNP icon
40
CenterPoint Energy
CNP
$27.7B
$480K 0.25%
17,332
-268
-2% -$7.03K
HD icon
41
Home Depot
HD
$331B
$449K 0.24%
2,300
– –
LLY icon
42
Eli Lilly
LLY
$1.02T
$448K 0.24%
5,253
– –
MRK icon
43
Merck
MRK
$322B
$405K 0.21%
6,987
+84
+1% +$4.74K
BNY
44
Bank of New York Mellon
BNY
$106B
$378K 0.2%
7,000
– –
VAR
45
DELISTED
Varian Medical Systems, Inc.
VAR
$351K 0.19%
3,090
+40
+1% +$4.79K
LOW icon
46
Lowe's Companies
LOW
$117B
$334K 0.18%
3,500
– –
IBM icon
47
IBM
IBM
$211B
$326K 0.17%
2,443
-36
-1% -$5.02K
BMY icon
48
Bristol-Myers Squibb
BMY
$133B
$317K 0.17%
5,720
-1,700
-23% -$91.8K
BEN icon
49
Franklin Resources
BEN
$17.6B
$284K 0.15%
8,850
– –
HRL icon
50
Hormel Foods
HRL
$13.8B
$277K 0.15%
7,445
-180
-2% -$6.46K
1
2
3

Similar funds

LWP
LeClair Wealth Partners Dublin, Ohio $289M AUM 19.98% 1-Year Est. Return
BWAM
Blue Water Asset Management Grand Rapids, Michigan $289M AUM
WPWM
Windward Private Wealth Management Overland Park, Kansas $289M AUM 12.08% 1-Year Est. Return
PIA
PineBridge Investments Asia Hong Kong $289M AUM
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
GIM
Goodlander Investment Management Dallas, Texas $289M AUM 225.62% 1-Year Est. Return
PSA
Plum Street Advisors New Orleans, Louisiana $289M AUM 17.28% 1-Year Est. Return
SI
Saxon Interests Houston, Texas $290M AUM 19.97% 1-Year Est. Return

Bourne Lent Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bourne Lent Asset Management held 58 positions worth $190M, up 3% from $184M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bourne Lent Asset Management's Q2 2018 filing shows 3 new, 14 increased, 18 reduced and 1 closed positions. Its largest new stake was L3Harris: 1,750 shares worth $253K. The largest sale was Monsanto Co, an estimated $1.83M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Communication Services.

  • Bourne Lent Asset Management's largest Q2 2018 buy was L3Harris: 1,750 shares worth $253K.
  • Bourne Lent Asset Management added most to Amazon in Q2 2018, an estimated $413K increase.
  • Bourne Lent Asset Management's biggest Q2 2018 reduction was Idexx Laboratories, cutting an estimated $1.04M.
  • Bourne Lent Asset Management fully exited Monsanto Co in Q2 2018, selling an estimated $1.83M.
  • Bourne Lent Asset Management's ten largest holdings make up 76% of its $190M portfolio in Q2 2018.
  • Bourne Lent Asset Management opened 3 new positions and closed 1 in Q2 2018.
  • Bourne Lent Asset Management's portfolio value rose 3% quarter-over-quarter to $190M.

Based on Bourne Lent Asset Management's 13F filing for Q2 2018, filed 25 Jul 2018.